These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26567722)

  • 21. Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.
    Sica DA; Halstenson CE; Gehr TW; Keane WF
    Clin Pharmacokinet; 2000 Jun; 38(6):519-26. PubMed ID: 10885588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
    Sarafidis PA; Persu A; Agarwal R; Burnier M; de Leeuw P; Ferro CJ; Halimi JM; Heine GH; Jadoul M; Jarraya F; Kanbay M; Mallamaci F; Mark PB; Ortiz A; Parati G; Pontremoli R; Rossignol P; Ruilope L; Van der Niepen P; Vanholder R; Verhaar MC; Wiecek A; Wuerzner G; London GM; Zoccali C
    Nephrol Dial Transplant; 2017 Apr; 32(4):620-640. PubMed ID: 28340239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definition, identification and treatment of resistant hypertension in chronic kidney disease patients.
    Drexler YR; Bomback AS
    Nephrol Dial Transplant; 2014 Jul; 29(7):1327-35. PubMed ID: 24046194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of the dialysis bath in the control of arterial hypertension in patients receiving regular hemodialytic treatment].
    Stratta P; Segoloni GP; Ragni R; Coppo R; Camussi G; Jeantet A; Piccoli G
    Arch Sci Med (Torino); 1974; 131(4):211-5. PubMed ID: 4458633
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood pressure variability in chronic kidney disease patients.
    Mallamaci F; Tripepi G
    Blood Purif; 2013; 36(1):58-62. PubMed ID: 23735729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Pro position.
    Agarwal RL
    J Am Soc Hypertens; 2012; 6(6):439-42. PubMed ID: 23079076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic kidney disease in adrenal disorders.
    Salman LA; Cohen DL
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):312-317. PubMed ID: 33741779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Con position.
    Weir MR
    J Am Soc Hypertens; 2012; 6(6):443-7. PubMed ID: 23127361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home and ambulatory blood pressure monitoring in chronic kidney disease.
    Agarwal R
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):507-12. PubMed ID: 19713838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradialysis Hypertension in End-Stage Renal Disease Patients: Clinical Epidemiology, Pathogenesis, and Treatment.
    Georgianos PI; Sarafidis PA; Zoccali C
    Hypertension; 2015 Sep; 66(3):456-63. PubMed ID: 26150436
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
    Ku E; Glidden DV; Johansen KL; Sarnak M; Tighiouart H; Grimes B; Hsu CY
    Kidney Int; 2015 May; 87(5):1055-60. PubMed ID: 25493952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure targets in CKD.
    Townsend RR
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):96-101. PubMed ID: 25704345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT).
    Zazgornik J; Biesenbach G; Forstenlehner M; Stummvoll K
    Clin Nephrol; 1997 Dec; 48(6):337-40. PubMed ID: 9438090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure goals and treatment in pregnant patients with chronic kidney disease.
    Hussain A; Karovitch A; Carson MP
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):165-9. PubMed ID: 25704354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects of hypertension management in patients with chronic kidney disease].
    Vakilzadeh N; Phan O; Forni Ogna V; Burnier M; Wuerzner G
    Rev Med Suisse; 2014 Sep; 10(441):1668-72. PubMed ID: 25322626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equal levels of blood pressure control in ESRD patients receiving high-efficiency hemodialysis and conventional hemodialysis.
    Velasquez MT; von Albertini B; Lew SQ; Mishkin GJ; Bosch JP
    Am J Kidney Dis; 1998 Apr; 31(4):618-23. PubMed ID: 9531177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in chronic dialysis patients: pathophysiology, monitoring, and treatment.
    Morse SA; Dang A; Thakur V; Zhang R; Reisin E
    Am J Med Sci; 2003 Apr; 325(4):194-201. PubMed ID: 12695724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.